Clinical Trial Update: Yellow Fever Vaccination Under Low Dose Methotrexate Therapy

View source ↗

Summary

Clinical trial update about yellow fever vaccination in patients receiving low-dose methotrexate for rheumatic or dermatologic disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatologic Diseases
• Rheumatic Diseases

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Yellow fever vaccine (live attenuated yellow fever vaccine)

Snippet

Sponsor: University of Zurich | Conditions: Rheumatic, Dermatologic Disorders | Status: UNKNOWN